Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Operating Leases (2020 - 2025)

Journey Medical filings provide 6 years of Operating Leases readings, the most recent being $18000.0 for Q4 2025.

  • On a quarterly basis, Operating Leases fell 84.75% to $18000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $18000.0, a 84.75% decrease, with the full-year FY2025 number at $18000.0, down 84.75% from a year prior.
  • Operating Leases hit $18000.0 in Q4 2025 for Journey Medical, down from $44000.0 in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $118000.0 in Q4 2024 to a low of $9000.0 in Q4 2023.
  • Median Operating Leases over the past 5 years was $59000.0 (2023), compared with a mean of $60090.9.
  • Biggest five-year swings in Operating Leases: crashed 91.67% in 2023 and later surged 1211.11% in 2024.
  • Journey Medical's Operating Leases stood at $24000.0 in 2021, then skyrocketed by 350.0% to $108000.0 in 2022, then crashed by 91.67% to $9000.0 in 2023, then surged by 1211.11% to $118000.0 in 2024, then crashed by 84.75% to $18000.0 in 2025.
  • The last three reported values for Operating Leases were $18000.0 (Q4 2025), $44000.0 (Q3 2025), and $69000.0 (Q2 2025) per Business Quant data.